Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Opus Genetics, Inc. | President, Director | Common Stock | 333K | $393K | $1.18 | Nov 7, 2024 | Direct |
Clearside Biomedical, Inc. | Director | Common Stock | 18K | $23.5K | $1.31 | May 15, 2024 | Direct |
Clearside Biomedical, Inc. | Director | Stock Option (right to buy) | 45K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IRD | Opus Genetics, Inc. | Nov 7, 2024 | 1 | $0 | 4 | Nov 12, 2024 | President, Director |
IRD | Opus Genetics, Inc. | Oct 22, 2024 | 0 | $0 | 3 | Oct 24, 2024 | President, Director |
CLSD | Clearside Biomedical, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
CLSD | Clearside Biomedical, Inc. | May 15, 2024 | 1 | $10.2K | 4 | May 15, 2024 | Director |
CLSD | Clearside Biomedical, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
CLSD | Clearside Biomedical, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
CLSD | Clearside Biomedical, Inc. | Mar 2, 2022 | 1 | $0 | 4 | Mar 4, 2022 | Director |
CLSD | Clearside Biomedical, Inc. | Mar 2, 2022 | 0 | $0 | 3 | Mar 4, 2022 | Director |